Eton Pharmaceuticals Inc. (ETON)
ETON trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$53.33
-3.48% on the day
Market cap
$1.5B
Small cap
Revenue · 2025
$80.0M
+104.9% on 2024
Net income · 2025
-$4.6M
-5.8% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ETON on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2018 |
| SEC CIK | 0001710340 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $80.0M |
| Net income | -$4.6M |
| Operating income | -$844K |
| Net margin | -5.8% |
| Operating margin | -1.1% |
| Revenue growth | +104.9% |
| Cash | $25.9M |
| Total assets | $92.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 19.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B5 | 424B5 | 2024-12-12 |
| Latest annual report FORM 10-K | 10-K | 2026-03-19 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-13 |
| Latest current report FORM 8-K | 8-K | 2026-10-14 |
| Latest proxy FORM DEF 14A | DEF 14A | 2026-04-24 |
Source: SEC EDGAR submissions feed, 417 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -3.2% |
| 1 month | -3.3% |
| 3 months | +42.8% |
| Year to date | +214.0% |
| 1 year | +193.7% |
| From 52-week high | -17.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CMPS | COMPASS Pathways Plc American Depository Shares | $11.14 | -3.38% | $1.5B |
| INVA | Innoviva Inc. | $20.74 | -3.31% | $1.5B |
| PAHC | Phibro Animal Health Corporation | $36.81 | -1.66% | $1.5B |
| GENB | Generate Biomedicines Inc. | $12.26 | -11.45% | $1.6B |
| QURE | uniQure N.V. | $21.28 | -2.56% | $1.5B |
| RARE | Ultragenyx Pharmaceutical Inc. | $14.92 | -2.48% | $1.5B |
| OCUL | Ocular Therapeutix Inc. | $7.24 | -4.23% | $1.6B |
| GPCR | Structure Therapeutics Inc. | $22.31 | -6.69% | $1.6B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier